Suppr超能文献

经导管主动脉瓣置换术与冠状动脉介入治疗患者对比造影剂致急性肾损伤。

Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions.

机构信息

Division of Cardiology Department of Medicine University of Verona Italy.

出版信息

J Am Heart Assoc. 2020 Aug 18;9(16):e017194. doi: 10.1161/JAHA.120.017194. Epub 2020 Aug 13.

Abstract

Background Differences in the impact of contrast medium on the development of contrast-induced acute kidney injury (CI-AKI) in patients undergoing transcatheter aortic valve implantation (TAVI) or a coronary angiography/percutaneous coronary intervention (CA/PCI) have not been previously investigated. Methods and Results Patients treated with TAVI or elective CA/PCI were retrospectively analyzed in terms of baseline and procedural characteristics, including preprocedural and postprocedural kidney function. CI-AKI was defined as a relative increase in serum creatinine concentration of at least 0.3 mg/dL within 72 hours of contrast-medium administration compared with baseline. The incidence of CI-AKI in the TAVI versus CA/PCI group was compared. After the exclusion of patients in dialysis and emergency procedures, 977 patients were analyzed; there were 489 patients who had undergone TAVI (50.1%) and 488 patients who had undergone CA/PCI (49.9%). Patients treated by TAVI were older, presenting a higher rate of anemia and chronic kidney disease (<0.001 for all comparisons). Consistently, they also had a significantly lower glomerular filtration rate and higher serum creatinine concentration (<0.001 for all). However, the occurrence of CI-AKI was significantly lower in these patients compared with patients treated by a CA/PCI (6.7% versus 14.5%, <0.001). At multivariate analysis, the TAVI procedure had an independent protective effect on CI-AKI incidence among total population (odds ratio, 0.334; 95% CI, 0.193-0.579; <0.001). This observation was confirmed after propensity score matching among 360 patients (180 by TAVI and 180 by CA/PCI; =0.002). Conclusions CI-AKI occurred less frequently in patients undergoing TAVI than in patients undergoing a CA/PCI, despite a worse-risk profile. The impact of contrast administration on kidney function in patients who had undergone TAVI may be better tolerated because of the hemodynamic changes following aortic valve replacement.

摘要

背景

经导管主动脉瓣植入术(TAVI)或冠状动脉造影/经皮冠状动脉介入治疗(CA/PCI)患者对比剂对对比剂诱导的急性肾损伤(CI-AKI)发展的影响存在差异,但尚未得到研究。

方法和结果

回顾性分析了接受 TAVI 或择期 CA/PCI 治疗的患者的基线和手术特征,包括术前和术后肾功能。CI-AKI 定义为与基线相比,对比剂给药后 72 小时内血清肌酐浓度至少升高 0.3mg/dL。比较 TAVI 组与 CA/PCI 组的 CI-AKI 发生率。排除透析和急诊患者后,分析了 977 例患者;其中 489 例患者接受 TAVI(50.1%),488 例患者接受 CA/PCI(49.9%)。接受 TAVI 治疗的患者年龄较大,贫血和慢性肾脏病的发生率较高(所有比较均<0.001)。一致地,他们的肾小球滤过率也明显较低,血清肌酐浓度较高(所有比较均<0.001)。然而,与接受 CA/PCI 治疗的患者相比,这些患者的 CI-AKI 发生率明显较低(6.7%与 14.5%,<0.001)。多变量分析显示,TAVI 术在总人群中对 CI-AKI 发生率具有独立的保护作用(比值比,0.334;95%置信区间,0.193-0.579;<0.001)。在 360 例患者中进行倾向评分匹配后(180 例接受 TAVI 治疗,180 例接受 CA/PCI 治疗;=0.002),观察结果得到了证实。

结论

尽管风险状况较差,但与接受 CA/PCI 治疗的患者相比,接受 TAVI 治疗的患者发生 CI-AKI 的频率较低。主动脉瓣置换术后血流动力学变化可能使 TAVI 患者对对比剂对肾功能的影响具有更好的耐受性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b5c/7660800/bbc1220a1773/JAH3-9-e017194-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验